Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Two loss years in a row NBB
Negative result in 2024 and 2025.
-
Busy address KBO
31 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
Railroad Therapeutics from Charleroi, company number BE0792976285, closed financial year 2025 with a result of € -127,809 after tax. For that financial year Railroad Therapeutics recorded a gross margin of € -28,240 and equity of € 437,751. Compared with financial year 2024, the result moved from € -80,862 to € -127,809. The company made a loss. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 28, 2026.
€ 437,751
▲ € 493,695 vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -127,809
▼ 58 % more loss than in 2024
Profit after tax over the fiscal year.
€ 529,988
▲ € 458,403 vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -198,753.
People and assets in 2025
€ 62,879
▲ 3% vs 2024
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 29,212
▲ 203% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 4,710
Wages, holiday pay and social contributions still to pay. No outstanding taxes.
| 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|
| Gross margin | € 75,874 | € 73,752 | € -28,240 | ▼ € 101,992 |
| Profit after taxes | € 9,918 | € -80,862 | € -127,809 | ▼ € 46,947 |
| Equity | € 24,918 | € -55,944 | € 437,751 | ▲ € 493,695 |
| Total debts | € 247,883 | € 199,752 | € 181,871 | ▼ 9% |
| Cash | € 51,343 | € 71,585 | € 529,988 | ▲ € 458,403 |
| Retained profit | € 9,918 | € -70,944 | € -198,753 | ▼ € 127,809 |
| Bank debt | € 190,000 | € 190,000 | € 0 | ▼ 100% |
| Balance sheet total | € 272,801 | € 143,808 | € 619,622 | ▲ € 475,815 |
Key figures of Railroad Therapeutics, fiscal years 2023 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Railroad Therapeutics?
What happened at Railroad Therapeutics in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 127,809. Source: NBB ↗
- Sofie Pattyn became a director. NBB
- Yvan Sergeant became a director. NBB
- 6K venture capital became a director. NBB
- Jakub Swiercz became a director. NBB
- Sciensation became a director. NBB
- New establishment in Charleroi. KBO
- Start of the company according to the CBE. KBO
In short
From € 9,918 profit in 2023 to € 127,809 loss in 2025.
Best year ever: 2023, with € 9,918 profit.
Management
The stake of 6K venture capital comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
Railroad TherapeuticsBehind Railroad Therapeutics are 6K venture capital, Sofie Pattyn, Jakub Swiercz, Yvan Sergeant and Sciensation. The shares are held by 6K venture capital (10.2%).
Directors
According to the 2025 annual accounts
Director · represented by Cédric Szpirer
Also active at: Charleroi Entreprendre, Brussels South Charleroi BioPark Dev, HOME EOS, FONDS D'INVESTISSEMENT POUR LA DIVERSIFICATION INDUSTRIELLE DE LA REGION DE CHARLEROI, Biometh Quality Product, FLIPAW, TAFSQUARE, XIMEO +7 more
since 2025
since 2025
Jakub Swiercz
Director
since 2025
Yvan Sergeant
Director
since 2025
Director · represented by Frédéric Sallmann
since 2025
Shareholders
10.2%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Rue Clément Ader 10
6041 Charleroi
Rue Auguste Piccard 48
6041 Charleroi
Active since 27 October 2022
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 31 companies are registered at this address.
All companies at this address →Brussels South Charleroi BioPark Dev same network
€ 80,186 gross margin · 2025
ImmunXperts same network
€ 393,338 gross margin · 2024
LYS MEDICAL
€ -309,203 gross margin · 2025
SPECTRALYS BIOTECH
€ 143,689 gross margin · 2025
ProtonW.be
€ -7,643 gross margin · 2025
+26 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0792.976.285
- VAT number
- BE 0792.976.285
- Registered office
- Rue Clément Ader 10, 6041 Charleroi
- Names & denominations
- Railroad Therapeutics
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 27 October 2022
- Peppol
- Active · Active since 1 Jan 2001
- Activities · NACE
Speur- en ontwikkelingswerk op biotechnologisch gebied
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied
Speur- en ontwikkelingswerk op het gebied van de maatschappij- en geesteswetenschappen
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied